| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | 57,9 k € | -12.5% | 66,1 k € | |
| EBITDA | 57,1 k € | -13.6% | 66,1 k € | |
| Operating profit | 55,7 k € | -15.0% | 65,6 k € | |
| Profit/loss | 43,2 k € | -16.7% | 51,9 k € | |
| Equity | 98,5 k € | +75.6% | 56,1 k € | |
| Total assets | 105,4 k € | +63.2% | 64,6 k € | |
| Cash | 92,4 k € | +76.5% | 52,3 k € | |
| Debts | 6,9 k € | -18.9% | 8,5 k € | |
| Staff | — | 0 | ||
Source: Belgian Official Gazette
Private limited company · Evere · incorporated on 30/01/2024
Private limited company profitable and well capitalised. Cash position rising (+76.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Harika Lifij is a Private limited company incorporated in 2024. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Evere.